About Us Services Careers FAQ Contact Us 0
Home Biotechnology Global Gene Synthesis Market Size to Hit USD 9.54 billion by 2033
Gene Synthesis Market

Gene Synthesis Market Size, Share & Trends Analysis Report By Method  (Solid-phase Synthesis, Chip-based Synthesis, PCR-based Enzyme Synthesis), By Service (Antibody DNA Synthesis, Viral DNA Synthesis, Others), By Application  (Gene and Cell Therapy Development, Vaccine Development, Disease Diagnosis, Others), By End-User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRBI2274DR
Last Updated : January 23, 2025
Author : Debashree Bora
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Gene Synthesis Market Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. U.S.
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Canada
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. U.K.
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. China
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. UAE
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Method 
      1. Introduction
        1. Method  By Value
      2. Solid-phase Synthesis
        1. By Value
      3. Chip-based Synthesis
        1. By Value
      4. PCR-based Enzyme Synthesis
        1. By Value
    3. By Service
      1. Introduction
        1. Service By Value
      2. Antibody DNA Synthesis
        1. By Value
      3. Viral DNA Synthesis
        1. By Value
      4. Others
        1. By Value
    4. By Application 
      1. Introduction
        1. Application  By Value
      2. Gene and Cell Therapy Development
        1. By Value
      3. Vaccine Development
        1. By Value
      4. Disease Diagnosis
        1. By Value
      5. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Biotechnology and Pharmaceutical Companies
        1. By Value
      3. Academic and Government Research Institutes
        1. By Value
      4. Contract Research Organizations
        1. By Value
    6. Brazil
      1. By Method 
        1. Introduction
          1. Method  By Value
        2. Solid-phase Synthesis
          1. By Value
        3. Chip-based Synthesis
          1. By Value
        4. PCR-based Enzyme Synthesis
          1. By Value
      2. By Service
        1. Introduction
          1. Service By Value
        2. Antibody DNA Synthesis
          1. By Value
        3. Viral DNA Synthesis
          1. By Value
        4. Others
          1. By Value
      3. By Application 
        1. Introduction
          1. Application  By Value
        2. Gene and Cell Therapy Development
          1. By Value
        3. Vaccine Development
          1. By Value
        4. Disease Diagnosis
          1. By Value
        5. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Biotechnology and Pharmaceutical Companies
          1. By Value
        3. Academic and Government Research Institutes
          1. By Value
        4. Contract Research Organizations
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Gene Synthesis Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. GenScript
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Brooks Automation, Inc. (GENEWIZ)
    3. Boster Biological Technology
    4. Twist Bioscience
    5. ProteoGenix
    6. Biomatik
    7. ProMab Biotechnologies, Inc.
    8. Thermo Fisher Scientific, Inc.
    9. Integrated DNA Technologies, Inc.
    10. OriGene Technologies, Inc. 
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Geosynthetics Market Size The global Geosynthetics Market Size was valued at USD 16.08 billion in 2024 and is projected to reach from USD 17.08 billion in 2025 to USD 27.64 billion by 2033, growing at a CAGR of 6.2%&nbs
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.